Dot Compliance has launched a ready-to-use AI-based electronic quality management system (eQMS) for the life sciences sector. The system uses embedded generative and predictive artificial intelligence (AI) alongside chatbots to automate tasks, free up personnel to focus on more important matters, and enhance compliance. The technology can improve the efficiency of quality management processes, thereby speeding up drug development, approval and launch, while mitigating the risk of regulatory penalties, product recalls and reputational damage. Over the past three years, the FDA and other regulators have imposed more than $100m in fines on life sciences companies for quality and safety standards breaches.
What You Should Know:
- Dot Compliance, a leading provider of eQMS compliance solutions for the life sciences sector, has introduced an industry-first, ready-to-use AI-Based electronic Quality Management System for life sciences, powered by an embedded generative and predictive artificial intelligence.
- The system deploys ChatGPT combined with proprietary algorithms to optimize quality processes, automate tasks and help professionals working in quality assurance to focus on what really matters while enhancing the compliance of their organizations.
AI-Driven Algorithms to Improve Healthcare Quality
Over the last three years, the FDA, EMA and other regulators have issued over $100 million in fines to life sciences companies for violations related to quality and safety standards, and with the average cost of leading a new drug to market being over $2.6 billion, the losses incurred due to delays or mistakes can be colossal. Cutting through the complexity of regulatory demands takes a significant investment of time and manpower, which inevitably impacts the survival of a life science company, impedes the likelihood of drugs reaching shelves and ultimately, limits patient access to the right medicines and medical devices at the right time. The use of AI to make informed decisions and enforce good quality management practices (GMP) can reduce these costs.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
“It is like having a quality assurance specialist by your side, at all times. The augmented use of AI is broadening horizons for personnel in the quality arena and is unparalleled in terms of productivity and speed. The Life Science industry has quite rightfully a meticulous, yet painstaking process for stewarding new products to market. This process must remain as safe and detailed as is required, but it can be made exponentially more efficient. Dot Compliance has embedded advanced AI capabilities with QMS, building a level of insight that is so far unrivaled. We are the first company to introduce generative AI to the quality and compliance space in this way,” said Doron Sitbon, Founder & CEO at Dot Compliance.
Quality management is a mission critical activity for pharmaceutical and medical device organizations. Failure to implement effective quality management measures to ensure the safety and efficacy of products result in a range of undesirable consequences, such as product recalls, regulatory fines, legal liabilities, damage to brand reputation, and harm to patients. The Dot Compliance Suite includes an extensive set of fully pre-validated ready to use eQMS processes. QMS Xpress, the company’s flagship solution, is out of the box and ready to use, enabling customers to deploy quickly in a cost-effective way. Dot Compliance Xpand provides additional processes to support an organization’s growing quality needs.
Through Dot Compliance’s solution, manufacturers can seamlessly integrate AI-driven quality management systems into their existing processes and benefit from an AI platform that constantly learns – enhancing its performance over time and providing increasingly accurate insights and predictions. The technology improves overall efficiency of quality management processes, enabling faster product development, approval, and market launch, while minimizing the risks associated with costly regulatory penalties, recalls, and reputational damage. With hundreds of customers globally, and tens of thousands of users, Dot Compliance’s cost-effective and AI-powered QMS solution helps the life science industry reach millions of patients, who would otherwise be left waiting.
Source: HitConsultant
